Deletion of CD137 ligand exacerbates renal and cutaneous but alleviates cerebral manifestations in Lupus
10.3389/fimmu.2019.01411
Saved in:
Main Authors: | Mak, A., Dharmadhikari, B., Kow, N.Y., Thamboo, T.P., Tang, Q., Wong, L.W., Sajikumar, S., Wong, H.Y., Schwarz, H. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/212333 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus
by: Mak, A., et al.
Published: (2021) -
C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation
by: Teh, B.K., et al.
Published: (2014) -
CD137L-DCs, Potent Immune-Stimulators—History, Characteristics, and Perspectives
by: Zeng, Q., et al.
Published: (2021) -
Regulatory t cells inhibit t cell activity by downregulating cd137 ligand via cd137 trogocytosis
by: Luu, Khang, et al.
Published: (2022) -
Long-term prognostic significance of interleukin-17-producing T cells in patients with non-small cell lung cancer
by: Song, L., et al.
Published: (2021)